Navigation Links
Hotspur Technologies Commences US Launch at Veith/AIM Conference in New York City
Date:11/16/2011

NEW YORK, Nov. 16, 2011 /PRNewswire/ -- Hotspur Technologies today announced the launch of the company's GPSCath™ Balloon Dilatation Catheter in the United States and select international markets.  The company made the announcement today.  

Hotspur's innovative GPSCath™ Balloon Dilatation Catheter integrates a proprietary valve into a balloon catheter, allowing physicians to inject contrast during a procedure without the need for removal of the balloon catheter or adjustment of guidewire position.  Combining these multiple functions into one device can potentially reduce the time and expense required to complete peripheral angioplasty procedures, allowing physicians to work more efficiently.

To support this initial launch, Hotspur has entered into exclusive distribution agreements with SurgPro, LLC, and TD Medical, leading medical device distributors in the interventional radiology space for the southeastern United States and the Netherlands, respectively.  While these regions are the initial focus of Hotspur's launch, the company will continue to expand its distribution network throughout the United States and other select international markets in 2012.

"My use of the GPSCath™ has been a highly positive experience, and I look forward to using more of these devices in the future as well as seeing what other innovations Hotspur will bring to the market," said Dr. Tom DiBartholomeo, an interventional radiologist and early adopter of the product.

During the company's recently completed limited market launch, over 150 GPSCath™ balloon catheters were successfully used in more than 100 dialysis access procedures.  This initial product experience validated the performance of both the angioplasty and injection functions of the GPSCath™, while also reinforcing the benefit of combining the multiple functions into one unique catheter.  

"I am very excited about the launch of GPSCath™.  We have been very impressed with the device performance, and we feel that the GPSCath™ will make a significant impact in providing better care for patients and reducing procedure times for physicians," said Gwen Watanabe, President & CEO of Hotspur Technologies. "In the near future, I am also looking forward to launching a number of new novel products in the US market, which will underscore the strength of the company's pipeline and the depth of our R&D."

About Hotspur Technologies

Founded in 2008 and located in Mountain View, California, Hotspur Technologies (www.hotspur-inc.com) is a leading developer of catheter-based technologies aimed at restoring blood flow for patients with obstructed vessels.  The company's products are based on a unique technology that opens blood vessels more efficiently and less invasively. The firm's VisioValve™ technology serves as a launching point to improve patient outcome and physician efficiency. Hotspur is privately held.  Its investors include ONSET Ventures, Finistere Ventures, BioStar Ventures, Saratoga Ventures, Millennium Life Sciences Ventures, Incept, and Versant Ventures.

CONTACT: Will Martin, (770) 639-2777, will@hotspur-inc.com


'/>"/>
SOURCE Hotspur Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hotspur Technologys Novel 3-in-1 Angioplasty Balloon Successfully Achieves First Commercial Deployment
2. Hotspur Technologies Continues to Bring Innovations to Peripheral Vascular Market
3. First Hotspur Peripheral Angioplasty Case Completed
4. Hotspurs Keeper Embolectomy Catheter Deployed for First Time
5. Hotspur Technologies’ IQCath Catheter Receives CE Mark
6. Hotspur Technologies Appoints Fred Khosravi Chairman of the Board
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
11. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their approach ... patient is doing more than filling out a survey; in many cases health professionals ... emphasis in health care and research on the importance of active engagement with patients ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association ... standards of excellence for the field of eating disorders, announces the opening of ... 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. , ...
(Date:10/13/2017)... ... , ... Lori R. Somekh, founder of the Law Office of Somekh ... law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up ... network with elder law attorneys nationwide,” said Somekh. , ElderCounsel was ...
(Date:10/13/2017)... ... ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to host ... items from across the nation, this holiday-themed event will raise funds and awareness for ... The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 p.m.) ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
Breaking Medicine News(10 mins):